Mode of action of aspirin-like drugs.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001095:Arachidonic Acids / Q000378:metabolism; D001241:Aspirin / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D003864:Depression, Chemical; D004487:Edema / Q000139:chemically induced; D011464:Epoprostenol / Q000627:therapeutic use; D004890:Erythema / Q000139:chemically induced; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy; D011448:Prostaglandin Antagonists / Q000494:pharmacology; D011453:Prostaglandins / Q000096:biosynthesis* / Q000378:metabolism; D011458:Prostaglandins E / Q000494:pharmacology; D011460:Prostaglandins F / Q000494:pharmacology; D013927:Thrombosis / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001095:Arachidonic Acids; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D011464:Epoprostenol; D001241:Aspirin